Influenza Vaccine Enhancement Patch: Completed Phase I enrollment

Intercell disclosed in its 4Q11 earnings that it completed enrollment of 300 healthy adults in an open-label, European Phase I trial comparing its Influenza VEP in combination with GlaxoSmithKline's H...